Milacemide

From WikiMD's Wellness Encyclopedia

Milacemide is a pharmaceutical drug that was developed for potential use in the treatment of Alzheimer's disease and other cognitive disorders. It is a prodrug of glycine, an amino acid that acts as a neurotransmitter in the central nervous system.

History[edit | edit source]

Milacemide was first synthesized in the 1980s by Sanofi, a French multinational pharmaceutical company. It was developed as a potential treatment for Alzheimer's disease, a neurodegenerative disorder characterized by progressive memory loss and cognitive decline. However, clinical trials did not show significant benefits, and the drug was never marketed.

Pharmacology[edit | edit source]

Milacemide is a prodrug of glycine, meaning it is metabolized in the body to produce glycine. Glycine is an amino acid that acts as a neurotransmitter in the central nervous system. It is involved in various physiological processes, including the modulation of NMDA receptor activity. NMDA receptors are involved in learning and memory, and their dysfunction is implicated in the pathogenesis of Alzheimer's disease.

Clinical trials[edit | edit source]

In clinical trials, milacemide was found to be well-tolerated but did not show significant benefits in improving cognitive function in patients with Alzheimer's disease. Some studies suggested that it might have a beneficial effect on mood and behavior, but these findings were not consistent across trials.

Current status[edit | edit source]

As of now, milacemide is not approved for use in any country. Research into its potential uses continues, particularly in the context of neurodegenerative disorders and psychiatric conditions.

See also[edit | edit source]






This neurotransmitter-related article is a stub. You can help WikiMD by expanding it.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD